JUXIN BIOPHARMACEUTICAL CO., LTD

   Juxin Biopharmaceutical Co., Ltd. was founded in 2012, is located in Dancheng County high-tech zone, covers an area of 258 acres, the existing staff of 416 people, mainly engaged in pharmaceutical manufacturing industry of pharmaceutical intermediates, raw materials, reagents and preparation products research and development, production, sales and export of high-tech enterprises. Products Anti-AIDS intermediates Abacavir and treatment cardio-cerebrovascular intermediates Diltiazem hydrochloride are national "863" program products; Cloxacillin benzacin, the core product of the API, is a product with GMP certification and approval number. Products are exported to Europe, America, Russia, Japan, Korea and India and other more than 70 countries and regions.

    The company attaches great importance to the research and development of new products and new technologies and the transformation of results, relying on Academician Deng Zixin and Wuhan University, Zhengzhou University and other domestic scientific research teams, a total of 46 national patents, national 863 program project 2, Henan Province, Zhoukou City major science and technology projects each;  It has been recognized as A state-level high-tech enterprise, gazelle enterprise, innovative pilot enterprise, industry-education integration enterprise, intellectual property advantage enterprise, specialized and special new enterprise, three-system certification enterprise, quality system construction A-level enterprise, etc. In 2022, it won the Zhoukou Reform and Innovation Award, Zhoukou Science and Technology rising Star Enterprise, Zhoukou Excellent Private Enterprise, etc. The municipal government approved the establishment of Zhoukou fermentation drug Industry Research Institute, and led the establishment of Zhoukou Pharmaceutical Industry Development Association; In 2023, it won the vice president unit of Henan Pharmaceutical Industry Association, Zhoukou Intelligent Workshop, Zhoukou science and technology innovation team.

    The company started listing work in 2017, and is now included in the provincial key listing reserve enterprises. At present, securities companies, accounting firms, law firms have entered the company, and are actively creating conditions, organizing materials, and preparing to report listing applications.